Body Vision Medical is a commercial-stage medical device company specializing in AI-driven, real-time, intraoperative imaging. Body Vision's FDA-cleared, CE-marked, ISO 13485 certified, and fully reimbursed LungVision™ platform addresses the unmet clinical need for diagnostics and treatment of lung cancer. LungVision has demonstrated superior clinical outcomes in over 2400 clinical procedures at leading lung centers across the globe. Leveraging 20 years of experience in lung cancer diagnostics, the LungVision platform transforms the way pulmonologists perform bronchoscopy, while significantly increasing the number of diagnostic procedures for early-stage lung cancer. LungVision is designed and developed from a deep understanding of the clinical need for a cost-effective, ground-up, unified and intelligence-driven platform, and integrates with existing equipment in the field of pulmonology, which has traditionally been underutilized. Through ongoing collaboration between physicians, clinical specialists, and engineers of different specialties, Body Vision continues to set a new standard of care for lung diagnostics. In addition to LungVision, Body Vision plans to introduce surgical markers for VATS or radiosurgery and, later, for minimally invasive treatment tools such as radio-frequency or microwave ablation. To learn more about Body Vision and its innovative medical solutions, please visit our website: www.bodyvisionmedical.com.